Our team
Meet our team of talented and passionate scientists ready to tackle antimicrobial resistance with us.
-
Adèle James
Co-founder & CTO
-
Alexandros Pantalis
Co-founder & CEO
-
Anaïs Ducroq
Associate lab manager
-
András Asbóth
Bioinformatician
-
Andrea Di Gioacchino
Data scientist
-
Chakib Benlakehal
Associate research scientist in the making
-
Houa Oukaci
Research technician
-
Ilias Theodorou
Senior Research Scientist
-
Isabela Rosas Pavón
Research technician in the making
-
Julia Burgan
Research Scientist
-
Manon Lemasson
Research Scientist / Lab Manager
-
Marine Feyereisen
Senior Research Scientist
-
Maud Billaud
Bioinformatician
-
Mayumi Suzuki
Research technician
-
Natalie Kuljanishvili
Associate Research Scientist
-
Romain Sausset
Research Scientist
-
Stan Debruyn
Founders’ associate
-
Adèle James
Co-founder & CTO
-
Alexandros Pantalis
Co-founder & CEO
-
Anaïs Ducroq
Associate lab manager
-
András Asbóth
Bioinformatician
-
Andrea Di Gioacchino
Data scientist
-
Chakib Benlakehal
Associate research scientist in the making
-
Houa Oukaci
Research technician
-
Ilias Theodorou
Senior Research Scientist
-
Isabela Rosas Pavón
Research technician in the making
-
Julia Burgan
Research Scientist
-
Manon Lemasson
Research Scientist / Lab Manager
-
Marine Feyereisen
Senior Research Scientist
-
Maud Billaud
Bioinformatician
-
Mayumi Suzuki
Research technician
-
Natalie Kuljanishvili
Associate Research Scientist
-
Romain Sausset
Research Scientist
-
Stan Debruyn
Founders’ associate
Our advisors
-
Daniel de Vos
Research Manager
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, world leader in human phage therapy.
-
Geoffroy Dubus
Partner at Demeter
Major European player in venture capital, private equity and infrastructure for the energy and ecological transition, Demeter manages €1.2bn and has completed 200 investments since its creation in 2005.
-
Pierre Belichard
Founder and CEO of Enterome
Enterome is a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on their unique ability to decode the gut microbiome’s interaction with the immune system. Enterome raised €116M to date.
-
Rob Kniaz
Partner at Hoxton Ventures
Early-stage venture capital firm investing in disruptive tech start-ups throughout Europe, Hoxton Ventures partners with founders seeking to invent new market categories or transform large, existing industries and accelerates their global expansion.
-
Daniel de Vos
Research Manager
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Brussels, world leader in human phage therapy.
-
Geoffroy Dubus
Partner at Demeter
Major European player in venture capital, private equity and infrastructure for the energy and ecological transition, Demeter manages €1.2bn and has completed 200 investments since its creation in 2005.
-
Pierre Belichard
Founder and CEO of Enterome
Enterome is a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on their unique ability to decode the gut microbiome’s interaction with the immune system. Enterome raised €116M to date.
-
Rob Kniaz
Partner at Hoxton Ventures
Early-stage venture capital firm investing in disruptive tech start-ups throughout Europe, Hoxton Ventures partners with founders seeking to invent new market categories or transform large, existing industries and accelerates their global expansion.